secwatch.observer — SEC 8-K summary
======================================

Issuer:     PDS Biotechnology Corp (PDSB)
CIK:        0001472091
Form:       8-K
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001140361-25-044940
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PDS Biotech receives broad Japanese patent for lead candidate PDS0101
---------------------------------------------------------------------

- Japan Patent Office issued Patent No. 7783866 for PDS0101 covering broad composition of matter and methods of use.
- Patent expands PDS Biotech's IP portfolio in Japan; previously granted patents in US, China, Australia, Hong Kong.
- Company anticipates patent and market protections for PDS0101 into the 2040s, including US biologics exclusivity.
- PDS0101 is in Phase 3 trial for HPV16-positive recurrent/metastatic head and neck cancer.
- CEO Frank Bedu-Addo stated the patent strengthens global IP and supports growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125044940/0001140361-25-044940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472091/000114036125044940/ef20060919_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-044940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer